Purcell R H, London W T, McAuliffe V J, Palmer A E, Kaplan P M, Gerin J L, Wagner J, Popper H, Lvovsky E, Wong D C, Levy H B
Lancet. 1976 Oct 9;2(7989):757-61. doi: 10.1016/s0140-6736(76)90598-5.
Chimpanzees chronically infected with hepatitis-B virus showed transient changes in several markers of infection when treated with the interferon inducer polyriboinosinic-polyribocytidylic acid-poly-l-lysine carboxymethyl cellulose. Serum Dane-particle-associated D.N.A. polymerase, e antigen and hepatitis-B surface antigen, and intrahepatic hepatitis-B surface and core antigens diminished during treatment. Defective (D.N.A.-polymerase-negative) Dane particles increased in titre transiently during treatment; these may play a role in the modulation of hepatitis-B virus infection. Humoral immune responses in chronic hepatitis-B carrier chimps were unaffected. Interferon inducers (or exogenous interferon) may be useful for the treatment of chronic hepatitis-B virus infection.
慢性感染乙型肝炎病毒的黑猩猩在接受干扰素诱导剂聚肌苷酸-聚胞苷酸-聚-L-赖氨酸羧甲基纤维素治疗时,几种感染标志物出现短暂变化。治疗期间,血清中与丹氏颗粒相关的DNA聚合酶、e抗原和乙型肝炎表面抗原,以及肝内乙型肝炎表面抗原和核心抗原减少。有缺陷的(DNA聚合酶阴性)丹氏颗粒在治疗期间滴度短暂升高;这些颗粒可能在乙型肝炎病毒感染的调节中起作用。慢性乙型肝炎携带黑猩猩的体液免疫反应未受影响。干扰素诱导剂(或外源性干扰素)可能对治疗慢性乙型肝炎病毒感染有用。